1-benzyl-3-(4-chloro-2-fluoro-phenyl)-N,4-dimethyl-N-(2-methylsulfonyl-ethyl)-5-(trifluoromethyl)-1H-pyrrole-2-carboxylic acid amide | 1574111-60-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 1-benzyl-3-(4-chloro-2-fluoro-phenyl)-N,4-dimethyl-N-(2-methylsulfonyl-ethyl)-5-(trifluoromethyl)-1H-pyrrole-2-carboxylic acid amide
• 英文别名: 1-benzyl-3-(4-chloro-2-fluorophenyl)-N,4-dimethyl-N-(2-methylsulfonylethyl)-5-(trifluoromethyl)pyrrole-2-carboxamide
• CAS: 1574111-60-6
• 化学式: C₂₄H₂₃ClF₄N₂O₃S
• 分子量: 530.971
• InChiKey: DJZDNRGWONTFCP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  35
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  67.8
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• [EN] FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES<br/>[FR] PYRROLE CARBOXAMIDES SUBSTITUÉS PAR UN FLUOROMÉTHYLE
  申请人：GRUENENTHAL GMBH

  公开号：WO2014032801A1

  公开（公告）日：2014-03-06

  The invention relates to pyrrole carboxamides bearing a fluoromethyl- moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

  这项发明涉及带有氟甲基基团的吡咯羧酰胺作为电压门控钙通道阻滞剂，以及含有这些化合物的药物组合物，还涉及这些化合物用于治疗和/或预防疼痛以及其他疾病和/或紊乱。
• FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES
  申请人：GRUNENTHAL GMBH

  公开号：US20140066426A1

  公开（公告）日：2014-03-06

  The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

  这项发明涉及带有氟甲基基团的吡咯酮羧酰胺作为电压门控钙通道阻滞剂，以及含有这些化合物的药物组合物，还涉及这些化合物用于治疗和/或预防疼痛以及其他疾病和/或紊乱。
• SUBSTITUTED PHENETHYLAMINES
  申请人：Gant Thomas G.

  公开号：US20080300316A1

  公开（公告）日：2008-12-04

  Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

  本文公开了Formula I的取代苯乙胺α肾上腺素受体调节剂，其制备方法，药物组合物以及使用方法。
• POLYAMIDE MOULDING COMPOUNDS AND THEIR APPLICATION
  申请人：PFLEGHAR Mark

  公开号：US20140066561A1

  公开（公告）日：2014-03-06

  This invention describes a thermoplastic moulding compound, specifically a polyamide moulding compound, consisting of: (A) 20-88% by weight thermoplastic synthetic, preferably polyamide; (B) 10-70% by weight fibre-shaped aggregates; (B1) 10-70% by weight glass fibres that consist primarily of silicon dioxide, aluminium oxide, and magnesium oxide; (B2) 0-20% by weight glass fibres that differ from the fibres in components (B1); (B3) 0-20% by weight additional fibre-shaped aggregates that differ from the fibres in components (B1) and (B2), are not based on glass, and are selected from the following group: carbon fibres, graphite fibres, aramide fibres, nanotubes; (C) 2-40% by weight particulate filler material; (D) 0-2% by weight additives; whereby the sum of (A) through (D) equals 100% weight.
• US9302988B2
  申请人：——

  公开号：US9302988B2

  公开（公告）日：2016-04-05